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Haploid ES cellsSome organisms such as yeast or males of social insects are haploid, i.e. they carry a single set of
chromosomes, while haploidy in mammals is exclusively restricted to mature germ cells. A single
copy of the genome provides the basis for genetic analyses where any recessive mutation of
essential genes will show a clear phenotype due to the absence of a second gene copy. Most
prominently, haploidy in yeast has been utilized for recessive genetic screens that have markedly
contributed to our understanding of development, basic physiology, and disease. Somatic mamma-
lian cells carry two copies of chromosomes (diploidy) that obscure genetic analysis. Near haploid
human leukemic cells however have been developed as a high throughput screening tool. Although
deemed impossible, we and others have generated mammalian haploid embryonic stem cells from
parthenogenetic mouse embryos. Haploid stem cells open the possibility of combining the power of
a haploid genome with pluripotency of embryonic stem cells to uncover fundamental biological
processes in deﬁned cell types at a genomic scale. Haploid genetics has thus become a powerful
alternative to RNAi or CRISPR based screens.
 2014 Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.1. Introduction
In recent years, new technologies such as transcriptional
proﬁling, genome sequencing, SNP mapping and GWAS analysis,
epigenetic proﬁles, proteomic or metabolomic proﬁling have
allowed us to collect large sets of genome wide data. However,
most of these datasets are of correlative nature and high through-
put functional analysis is still a challenge. Therefore, the functional
and phenotypic annotation of the human genome is a key task for a
fundamental understanding of development, normal physiology,
and disease pathogenesis. Phenotypic manifestation of genetic
variations in humans has become one important tool for functional
gene annotation. In model systems, forward genetic screens allow
for systematic identiﬁcation of genetic elements involved in a cer-
tain molecular and cellular process, while recessive genetics allows
for in depth study of a particular gene’s function.
As genetic perturbation typically manifests in phenotypes
recessively, yeast cells have proven to be a valuable tool for genetic
analysis [1]. This is made possible by their rapid cell cycle and
generation time as well as the fact that yeast can grow in a haploid
fashion. Thereby all induced mutations are homozygous and even
recessive mutations can reveal phenotypes. In more complex
model organisms, interbreeding of heterozygote animals istypically used to generate homozygous genomes. In some cases
such as in Drosophila melanogaster, induced mitotic recombination
at FRT sites (Flip recombination target) can be used to generate
homozygous clones of cells in the ﬁrst generation to allow for
efﬁcient genetic screens [2]. In mammals, direct assessment of
phenotypes in the ﬁrst generation in vivo as well as in in vitro cell
culture systems was nearly impossible until the discovery of RNAi.
Knockdown of transcripts by transfection/infection of cells with
siRNAs [3] or shRNAs [4] have allowed for large scale screens in cell
culture as well as in animals in vivo [5]. Recently, genome editing
systems such as Zn-ﬁngers [6], TALEN nucleases [7], and CRISPR [8]
have been developed for rapid genetic manipulation, importantly
also for the generation of homozygously mutated cells. CRISPR,
unlike the other systems, allows for the generation of complex
libraries for large scale genome editing. Furthermore, CRISPR can
be used to generate homozygous mutations at high frequency.
CRISPR is thus the only system that was already successfully used
for genome wide screens [9,10]. Nevertheless, efﬁciency, off-target
effects, and scalability are still challenges.
Here we review an alternative approach for genome wide
screens – haploid mammalian genetics. We discuss the advantages,
limitations, and technical requirements. Haploid genetics in mam-
malian cell culture is a rapidly growing ﬁeld that has proven its
impressive potency for gene discovery in a number of biomedical
research arenas, including resistance to bacteriotoxins [11,12]
and lectin toxins [13], identiﬁcation of viral host genes such as
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stem cell biology [16], as well as the elucidation of several signal-
ing pathways [17,18].
2. Blessings and curses of haploidy
Somatic cells almost always rely on a diploid chromosome set.
Exceptions to that rule are for instance males of many social
insects such as ants, which carry a single set of chromosomes, i.e.
they carry a haploid genome. Nature imposes enormous selective
pressure against any lethal or deleterious alleles in such haploid
insect males [19]. This mechanism is of special importance in large
insect states as the male fertilizing the queen will be supplying his
genes to many individuals. Such selection ensures ﬁtness of the
female population in the state. However, in most animals haploidy
is restricted to the end product of meiosis, the mature germ cells,
and ends with the fusion of male and female haploid genomes in
the fertilized zygote. Diploidy reduces expressive mutations in
somatic tissues and therefore ensures ﬁtness of individuals.
While diploidy allows for healthy populations, it also masks
most phenotypes in genetic experiments. Controlled reduction of
a diploid chromosome set to a completely haploid genome has
not been achieved yet by manipulation of mammalian cells.
Attempts to experimentally generate partially haploid genomes
rely on spontaneous chromosome loss upon cell fusion, e.g.
between human and rodent cells [20]. However, such cells are only
in part loosing human chromosomes while keeping the mouse gen-
ome and thus cannot be used to test for most recessive geneticA 
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achieved by activation of oocytes in absence of sperm via exposure to strontium or etha
injection (D), or removal of the female pronucleus from fertilized zygotes (E).traits. Some tumors, especially myeloid leukemias, harbor a
sub-diploid to near haploid genome [21–24] (Fig. 1A). In 1995,
Andersson and coworkers established a human leukemia cell line,
termed KMB-7, that contained a near haploid genome in early pas-
sages [25]. Additional genomic alterations in KMB-7 cells include
the Philadelphia chromosome or a fusion of chromosomes 9 and
22 giving rise to a BCR–ABL fusion protein. Kotecki et al. reported
the isolation of a near haploid KBM-7 subclone in 1999 that is hap-
loid in all chromosomes with the exception of chromosome 8 [26].
Diploidy of chromosome 8 is probably due to driver mutations, e.g.
in MYC, or due to the complementation of independent lethal
mutations on the two copies of chromosome 8. The mechanism
by which myeloid leukemic cells loose chromosomes and can still
live is not understood. Importantly, Kotecki et al. suggested that
such near-haploid tumor cells may be useful for recessive genetics
using retroviral insertional mutagenesis. However, it took another
10 years until the ﬁrst screens were published [11]. The use of near
haploid leukemic cells as model systems is limited due to cell iden-
tity and the underlying mutations that resulted in transformation.
A second approach for the generation of cells with a halved gen-
ome was introduced by the derivation of haploid medaka ﬁsh
embryonic stem cells [27]. This method relies on the reduction of
genome copy number by meiosis and hence resulted in ﬁsh cells
with a fully haploid genome.
The ﬁrst attempt to derive haploid mammalian embryonic stem
cells dates back to 1983, when Kaufman et al. derived ES cell lines
from unfertilized mouse oocytes (Fig. 1B and C) [28]. Parthenogen-
esis was induced by a short exposure to ethanol and oocytesE 
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cell lines carried a diploid chromosome set. In 2011, two groups,
including our group, reported the successful derivation of the ﬁrst
non-transformed mammalian haploid cells, namely murine hap-
loid ES cells [13,29]. In both cases, the Kaufmann protocol was
extended by a series of FACS sorts on haploid chromosome content
based on the assumption, that a rare subpopulation of haploid ES
cells may still exist (Fig. 1B).
Haploid mouse ES cells grow in 2i medium [29] as well as in LIF
plus serum [13]. Furthermore, haploid ES cells can be subcloned,
with single cell derived clones being capable of differentiation
in vivo and in vitro as well as the capacity for growth and mainte-
nance of stemness even under feeder free conditions [13]. A similar
approach to derive haploid murine ES cells was taken by the enu-
cleation of oocytes together with the supply of a sperm genome.
Maternal nuclei can be removed before (Fig. 1D [30,31] or after
(Fig. 1E) [31] fertilization. While activation of oocytes leads to a
maternally derived parthenogenetic cell line, replacement of
female chromosomes with a male genome results in so called
androgenetic cells.
One criticism of haploid cells as a model system is the ‘‘unnat-
ural’’ genome content with its implications to cellular identity.
However, for murine ES cells, it has been convincingly shown that
haploid ES cells fulﬁll all deﬁnitions of embryonic stem cells and
have full pluripotent capacity, as they can differentiate in all
three germ layers in vivo and in vitro, contribute to chimeric ani-
mals [13,29] and can even be passed through the germline by
blastocyst injection [30,32] or semicloning, i.e. injection of
haploid ES cells into mature oocytes [30]. What about haploinsuf-
ﬁcient gene loci? A long list of genes has been described that
manifest phenotypic aberrations, if the gene locus are reduced
to a single copy. One plausible explanation for the observed lack
of such effects in haploid ES cells might be that in a haploid cell
each protein will be reduced in abundance leading to observable
smaller cells and for instance transcription factors at half number
will only need to bind half the number of binding sites in a
nucleus. The relative abundance of genes, gene products, and
interaction partners will thus be almost normal. Some imbalances
in gene expression however may occur in monoallelically tran-
scribed loci. These loci include imprinted genes such as the
maternally expressed IGF2R [33], the paternally expressed gene
IGF-2 [34], or randomly silenced monoallelic expression such as
on the X chromosome. The exact expression states of such loci
still need to be elucidated.
During culture, haploid mammalian cell lines are enriched for
diploid populations. This is true both for parthenogenic ES cell lines
as well as for the spontaneously near haploid KBM-7 cell line [26].
Therefore, the selective in vivo advantage of aneuploidy leukemia
cells does not appear to be present in vitro even for near haploid
myeloid leukemias. Though the nature of the selective pressure
to become sub-diploid to near haploid is unknown, one possibility
could be a selection for reduced cell size in circulating tumor cells.
Possible mechanisms for subsequent diploidization are failed
cytokinesis or endoreplication. Cell fusion appears unlikely based
on the fact that induced mutations remain homozygous [11,13].
Importantly, upon differentiation of the ES cells, the haploid popu-
lation is lost. A likely explanation is the failure to compensate for
gene dosage on the X chromosome. Both, failure to inactivate as
well as complete inactivation of X encoded genes is not tolerated
in differentiated cells [35].
3. Genetic screens using haploid cells
The ﬁrst genome wide screens and thereby the proof of princi-
ple for functional genomics in near haploid mammalian KBM-7cells were published by Jan Carette in the laboratory of Thijn
Brummelkamp. Together, these authors demonstrated the power
of haploid genetics, by identifying host factors for bacterial toxins
[11,12], ﬁnding a candidate receptor for the Ebola virus [14], and
deciphering the biology of glycosylation by assaying Lassa virus
entry [36]. Our group performed the ﬁrst genome wide screen
using haploid mouse ES cells. Using this approach we identiﬁed
multiple host factors for the toxin ricin [13]. Other screens later
identiﬁed for instance entry ports for putative chemotherapeutic
compounds [37]. As all genetic screens, haploid screens consist of
three steps: Mutagenesis, selection, and mapping of mutations.
Of note, it is critical to work with a cell line with robust and stable
growth properties in cell culture. Both, KBM-7 cells as well as our
feeder free ES cell subclones display rapid growth, can readily be
sorted by FACS, and show a sufﬁciently low tendency to become
diploid, critical requirements for expansion of more than 109 cells
carrying a haploid genome.4. Mutagenesis
Haploid screens are ideally performed using massive parallel
hemizygous mutagenesis with up to >108 independently mutated
cells. While chemical or physical mutagenesis is easier to induce
and results in a wider variety of mutant alleles, the main advan-
tage of insertional mutagenesis is the presence of a known DNA
sequence at the site of integration. Mutations can thus be mapped
directly using PCR approaches. Loss of gene function is typically
achieved by including a strong splice acceptor sequence within
the inserted DNA element (Fig. 2A). Upon transcription of the
primary message, aberrant splicing into the splice acceptor will
result in premature termination of the peptide sequence upon
translation. Notably, the splice acceptor is only recognized if
inserted in the same orientation within the gene as the gene is
transcribed in. Splice acceptor cassettes are inserted into the
genome by making use of enzymatic reactions of mobile DNA
such as integrase (e.g. when packaged as retrovirus) [11,13] or
transposase [16].
A drawback of insertional mutagenesis is the presence of hot-
and cold spots of integration. While some loci are frequently hit,
others are avoided [38]. The effect is most pronounced for
retroviral integration [39]. Large scale mutagenesis in very high
complexity can in part overcome this issue. Furthermore, a bias
to integration sites in transcribed genes has been observed, espe-
cially if insertions are selected by resistance cassettes transcribed
from the genetic locus (gene trapping). Insertions in low or not
expressed genes will not result in positive selection due to
inefﬁcient transcription of the selection marker. Enhanced gene
trapping [40] by including enhancer elements in the mobile DNA
has therefore been developed to increase transcription at ‘‘silent’’
loci. Alternative methods to circumvent this problem are polyA
traps [41].5. Selection
Screening of haploid cells is typically done in pools (Fig. 2B).
Thereby, screens are efﬁcient, rapid, robust and genome wide.
Screens can be accomplished in less than one month. Due to the
vast number of cells and mutations, successful screens critically
depend on strong selection pressure, as few mutations resulting
in desired phenotypes must be separated from millions of cells
with wild type-like behavior. Most published screens therefore
use lethality as selection criteria. In addition, coupled to selection
markers, cellular reporter systems for surface receptors [15], sig-
naling pathways [17], or cellular identity [16] have been described.
Exon          sense       antisense 
 integration       integration 
Mutagenesis 
 Mutagenesis + Screen 
 
B 
F 
C E D 
insertion 
genomic DNA prep 
4-cutter digest 
ring ligation 
8-cutter digest & PCR 
iPCR Splinkerette PCR LAM-PCR 
insertion 
genomic DNA prep 
4-cutter digest 
adaptor ligation & PCR 
genomic DNA prep 
linear 
PCR 
purification and 
2nd strand 
synthesis 
restriction digest, 
adaptor ligation, 
nested 
PCR 
A 
Exon2 Exon1 SA Exon3 
SA 
Exon2 Exon1 SA Exon3 SA 
loss of function 
wild type 
LTR 
LTR 
LTR 
LTR 
Selection marker 
+ 
promoter 
SA 
SA 
SA 
SA 
Fig. 2. Insertional mutagenesis, screening, retrieval of mutations, and screen analysis. (A) Insertional mutagens such as transposons or retroviruses (LTR: long terminal
repeat) can be used to deliver splice acceptors (SA) into the genome. If splice acceptors are inserted in introns in sense relative to the transcripts, they will trap them and lead
to premature termination and loss of gene expression. Antisense integration will leave gene transcripts unharmed in most cases. (B) Diagram showing principles of haploid
screens. Upon optional reporter integration and insertional mutagenesis, cells are selected from a large pool. Thereby, millions of independent mutations can be assayed using
only a few plates within weeks. Extracted DNA is processed and subjected to deep sequencing using e.g. an Illumina platform. Different PCR based methods allow for the
identiﬁcation of multiple integration sites in parallel. (C–E) Inverse PCR relies on ring ligation of digested fragments and uses 2 locus speciﬁc primers (red), while splinkerette
PCR ligates linkers (splinkerette) to restriction digest fragments and thus uses only 1 locus speciﬁc primer. Splinkerette structure allows for initial priming only from the
speciﬁc primer. LAM-PCR (linear ampliﬁcation mediated PCR) is based on linear PCR with tagged primers. Tags allow for bead based single stranded DNA puriﬁcation followed
by second strand synthesis and semi-nested PCR upon tag ligation similar to splinkerette PCR. (F) Insertional mutagens will integrate in sense (green) or antisense (red) at
inter- as well as intragenic regions. Upon selection, exonic as well as intronic sense integrations are expected to remain in loci with selected loss of function phenotyes.
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For screen analysis, DNA of cells post-selection is puriﬁed, and
insertion sites are PCR ampliﬁed using insertion-site speciﬁc
sequences as primer binding sites. Alternative methods include
inverse PCR [42], Splinkerette PCR [43], as well as LAM-PCR [44],
all tools that allow for the identiﬁcation of millions of mutations
in parallel (Fig. 2C–E). Such PCR approaches can be set up as direct
input for next generation sequencing, which allows for compre-
hensive mapping of mutations from bulk cultures. As mutagenesis
occurs in parallel, each distinct integration site of a mutagen can be
considered an independent biological event.If multiple integration sites remain in the selected pool within
one gene locus, loss of the respective gene is likely to account for
the selected phenotype (Fig. 2F). For loss of function phenotypes,
insertions are expected to mostly reside in exons or in introns in
sense orientation relative to the gene. Accumulations of insertions
in genes can be plotted as the inverse distance to neighboring
integration sites (proximity index) [11] or as enrichment of gene
representation upon intersection with genomic features [13]. Some
transposons, in particular piggyback, display a tendency for local
hopping [45], i.e. re-excision and insertion in the genomic vicinity.
Local hopping can thus blur screening results, since presence of
multiple integration sites in close proximity conﬁne the ﬁnal
U. Elling, J.M. Penninger / FEBS Letters 588 (2014) 2415–2421 2419read-out of a screen, i.e. multiple insertions in one gene are inter-
preted as the gene being causal for the assayed phenotype [16].
Ideally, hundreds of independent mutations within a single gene
can be obtained [12]. Importantly, hotspots of mutagenesis have
to be normalized to integrational distribution of unselected cells.
7. Comparison to other methods developed for whole genome
screening
Screening haploid cells is extremely fast, cheap and can be done
in large pools. Similarly, RNAi and CRISPR based methods allow for
screens in large scale bulk cultures. However, these methods ﬁrst
require the generation of libraries (plasmids, virus) harboring
genome/transcriptome modifying activity by expressing guide- or
hairpin-constructs. Obtaining such libraries at high quality and
representation is still a bottleneck. Therefore, screens are often
performed on selected genes only. Data obtained from saturating
haploid genetic screens yield short lists of genes that almost all val-
idate [11–14,37]. In that way they currently outperform systems
like RNAi and CRISPR. The main reasons for that are (i) the number
of independent mutations targeting one gene in haploid screens is
much higher than independent hairpin or guide constructs in RNA
guided systems. Hundreds of distinct mutations may all point to
the same gene as being causal for the assayed phenotype. There-
fore statistics allows for much cleaner separation of hits from back-
ground. (ii) Mutations in haploid screens can be precisely mapped
to a deﬁned genomic modiﬁcation. In contrast, evidence for genetic
effects based on RNA-guided methods is indirect and the presence
of guide or hairpin is taken as indication for predicted genetic
effects. Due to the indirect nature of such approach, off-target
effects can blur results whenever this prediction does not hold
exclusively.
Key to successful identiﬁcation of hits is the possibility to
validate in secondary screens. Inducible RNAi allows for relief of
knockdown and thus potentially reversion of observed phenotype
[46]. In a similar fashion, haploid screens allow for in-pool
reversion of mutations by inversion or excision of splice acceptor
cassettes using Cre mediated recombination [47]. CRISPR inducedFig. 3. Drop-out screens using loss of function systems. Protein synthesis can be disrupted
based genome editing (B), or homozygous insertional mutagenesis using haploid cells (C)
red margin, gene disruption efﬁciency is shown as solid red ﬁlling (complete disruption) t
targeted cells will drop out from the population, while cells with no or minor effect on pro
cells harboring a particular RNA to be lost. The fraction of remaining cells limits the pote
screens are based on multiple independent mutations of which many will be complete los
same degree of protein disruption. Thus, all cells carrying an insertion with complete loss
assessed using PCR based approaches.micro-deletions based on non-homologous end joining, however,
allow only for individual ‘‘repair’’ of the targeted genome loci for
instance by cDNA expression. Thus, haploid genetics carry the
advantage of ‘‘clean’’ mutations that can be readily repaired and
screens at a genome-wide scale.
8. Expanding the screen-able space
A limitation of haploid-based approaches is the availability of
different haploid cell lines, while alternative methods such as RNAi
and CRISPR are more ﬂexible with the cell types that can be tar-
geted. To date only haploid embryonic stem cell lines as well as
haploid leukemia cells have been reported. However, ES cells for
mouse [13,29–31], rat [48], monkey [49], as well as near haploid
leukemia cell lines (e.g. KBM-7) are now available. The attempt
to reprogram KMB-7 into iPS cells additionally yielded the haploid
ﬁbroblast-like cell line HAP1 [14]. Working with various haploid
cell lines from different organisms increases the spectrum of ques-
tions that can be asked. KBM-7 and HAP1 cells have the advantage
of being of human origin and can thus be utilized to screen for
instance for human virus host factors. Haploid ES cells are more
ﬂexible in the possible signaling pathways that can be screened
due to the interplay of stemness and differentiation pathways.
Haploid ES cells offer the key advantage to expand the screen-able
space to different cell lineages: upon mutagenesis, they may be
transferred into other (now diploid) cell lineages while still carry-
ing the homozygous mutation that was set at haploid ES cell state.
Thereby it might be possible to set up screens in differentiated cell
types following haploid mutagenesis in ES cells.
Screening of millions of cells is limited by available assays suit-
able for such high throughput approaches. Hence, to date most
haploid screens were based on lethality of cells with toxic agents
or viruses and subsequent positive selection by outgrowth of resis-
tant clones. However, this approach is limited to a small number of
biological questions. For example, no microscopy/image analysis
screens in haploid cells have been reported yet. By the use of repor-
ter cell lines, surface molecules [15], signaling states [17], cellular
identity [16], and gene expression levels can be assayed. Fewin cells using complementing methods such as RNA-based knockdown (A), CRISPR-
. Cells targeted with a particular hairpin/guide within the population are shown with
o light red (ineffective gene product disruption). Upon negative selection, efﬁciently
tein activity will remain. (D) Small RNA-driven loss of function leads to a majority of
ntial degree of dropout. Biases in analysis may thus miss the real effect. (E) Haploid
s of function alleles; therefore all cells with a particular allele will be affected by the
of function (1–3) will completely disappear from the pool. Complete dropout can be
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reason is the technical challenges in setting up tight reporter sys-
tems that allow for the assay of millions of cells in a genome-wide
screen. Future haploid screens therefore should be developed
based on speciﬁc reporter systems, thereby opening haploid genet-
ics to a plethora of biological questions.
Finally, all published haploid cell screens are based on positive
selection, i.e. the remaining cells harbor the mutations of interest.
However, for many biological questions the ‘‘missing’’ mutants in a
given pool are of interest. For instance, which additional mutations
are synthetic lethal with oncogenic driver mutations? Which
mutations prevent cellular responses to stimuli? Which ones
hypersensitize to drug compounds? Hypersensitizing mutations
often identify drug targets and are therefore of great interest
[50]. Such negative selection screens, however, demand the quan-
titative evaluation of all mutations, not just the identiﬁcation of
enriched, positively selected mutants. Only if all mutations can
be quantiﬁed, it is possible to identify the mutations that were lost.
Even with today’s next generation sequencing possibilities, these
approaches are still limited by sequencing power. Given the devel-
opments in massive parallel sequencing, we predict, however, that
such limitations will be rapidly overcome in the near future.
For negative selection, haploid genetics has advantages over
alternative methods (Fig. 3A–C). In positive selection screens, inef-
ﬁcient knockdown in some cells as well as cells having avoided
editing the genome by CRISPR will be lost with little effect on
the ﬁnal experimental readout. However, the situation is different
in negative selection assays. All cells carrying a particular shRNA or
guide are assayed by quantiﬁcation of the representation of this
small RNA together. However, the effects of the RNA in the cell will
not be the same in each of the infected/transfected cells. Some cells
will for instance express the hairpin at too low levels resulting in
inefﬁcient knockdown or they generate a neutral in-frame deletion
on one or both alleles upon NHEJ subsequently to Cas9 induced
strand breaks. For negative selection however, a near 100% efﬁ-
ciency of gene loss is required, since any remaining cell may mask
the phenotype. If for instance, only 10% of cells transfected with a
particular hairpin/guide fail to inactivate the gene of inquiry
(Fig. 3D), the theoretically possible depletion of cells from the pool
with that construct can only be 10-fold (from 100% to 10% abun-
dance). Unfortunately, a 10-fold depletion is difﬁcult to identify
due to technical limitations, e.g. a PCR bias.
In contrast, an integration of a mutagen in haploid cells within a
particular position of the genome will result in the same genetic
effect in each cell harboring it. Most sense integrations in introns
will lead to a complete loss of the gene product in all cells with that
particular mutation and thereby results in reproducible and com-
plete depletion from the pool (Fig. 3E). Other mutations may intro-
duce incomplete loss of function alleles. However, as independent
integration sites are assayed separately, this will not affect the fully
depleting alleles. Haploid screens therefore represent an ideal plat-
form for negative selection since a certain genetic lesion set by
insertional mutagenesis will exert equal effects in all cells carrying
such an integration.
9. Conclusions
Haploid screens have demonstrated the power of ‘‘yeast genet-
ics’’ in mammalian cells and made the dream of genome wide
‘‘yeast’’ genetics in mammals come true. While still limited, the
number of available haploid cell lines is growing and reporter
based screens have added a new dimension of versatility. The
clear-cut results that can be obtained in well executed haploid
screens has the potential to outperform RNAi as well as published
CRISPR based screens and holds the promise to play an important
role in future genome-wide scans and functional gene annotations.Analysis of large datasets with millions of mutant clones was
unthinkable just a few years ago. The rapid development in next
generation sequencing in concert with the development of new
insertional mutagenesis systems for haploid genetics carry the
promise to revolutionize functional genomics and allow fast, near
whole genome-wide mutational forward genetics and reverse
genetics analysis in deﬁned cell types. Haploid stem cells addition-
ally combine the advantages of a haploid genome with the power
of pluripotency to uncover fundamental biological processes in
deﬁned cell types at a genomic scale.References
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